1. Home
  2. RBCAA vs PVLA Comparison

RBCAA vs PVLA Comparison

Compare RBCAA & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

HOLD

Current Price

$91.21

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$125.01

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBCAA
PVLA
Founded
1974
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
RBCAA
PVLA
Price
$91.21
$125.01
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
★ $231.25
AVG Volume (30 Days)
74.8K
★ 194.5K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
★ 2.15%
N/A
EPS Growth
N/A
★ 52.62
EPS
★ 0.77
N/A
Revenue
★ $417,495,000.00
$42,810,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.20
N/A
P/E Ratio
$119.76
★ N/A
Revenue Growth
8.50
★ 65.28
52 Week Low
$63.97
$68.96
52 Week High
$102.22
$161.38

Technical Indicators

Market Signals
Indicator
RBCAA
PVLA
Relative Strength Index (RSI) 45.70 40.41
Support Level $88.88 $119.42
Resistance Level $93.78 $136.35
Average True Range (ATR) 2.00 6.96
MACD 0.07 0.11
Stochastic Oscillator 47.75 33.19

Price Performance

Historical Comparison
RBCAA
PVLA

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: